A Meta‐Analysis of the Safety and Immunogenicity of Pharmacokinetic Similarity Studies and Comparative Clinical Studies

Documenti analoghi

• Comparison of Analysis of Covariance and Analysis of Variance in Pharmacokinetic Similarity Studies
  di: Brett A. Martini, et al.
  Pubblicazione: (2025)
• Approval of Upadacitinib in Pediatric Patients with Active Polyarticular Juvenile Idiopathic Arthritis or Active Psoriatic Arthritis: A Regulatory Perspective
  di: Lei He, et al.
  Pubblicazione: (2025)
• Model‐Informed Drug Development‐Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non‐Radiographic Axial Spondyloarthritis
  di: Dipak S. Pisal, et al.
  Pubblicazione: (2024)
• First‐in‐Human Dose Selection and Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Muscle‐Specific Kinase Agonist Adimanebart (ARGX‐119)
  di: Tonke van Bragt, et al.
  Pubblicazione: (2026)
• Pharmacokinetics, Safety, and Skin Irritation and Sensitization Potential of Clascoterone Cream in Early‐Phase Clinical Study Participants
  di: Andrea Francesco Daniele Di Stefano, et al.
  Pubblicazione: (2025)